Literature DB >> 11036207

Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons.

K L Grove1, R E Campbell, J M Ffrench-Mullen, M A Cowley, M S Smith.   

Abstract

Neuropeptide Y displays diverse modes of action in the CNS including the modulation of cortical/limbic function. Some of these physiological actions have been at least partially attributed to actions of neuropeptide Y on the Y5 receptor subtype. We utilized an antibody raised against the Y5 receptor to characterize the distribution of this receptor subtype in the rat cortical/limbic system and brainstem. Y5-like immunoreactivity was located primarily in neuronal cell bodies and proximal dendritic processes throughout the brain. In the cortex, Y5 immunoreactivity was limited to a subpopulation of small gamma-aminobutyric-acid interneurons (approximately 15 microm diameter) scattered throughout all cortical levels. Double label immunofluorescence was also used to demonstrate that all of the Y5 immunoreactive neurons in the cortex displayed intense corticotropin releasing hormone immunoreactivity. The most intense Y5 immunoreactive staining in the hippocampus was located in the pyramidal cell layer of the small CA2 subregion and the fasciola cinerea, with lower levels of staining in the hilar region of the dentate gyrus and CA3 subregion of the pyramidal cell layer. Nearly all of the Y5 immunoreactive neurons in the hilar region of the hippocampus displayed gamma-aminobutyric-acid immunoreactivity. In the brainstem, Y5 immunoreactivity was most intense in the Edinger-Westphal nucleus, locus coeruleus and the mesencephalic trigeminal nucleus. The present study provides neuroanatomical evidence for the possible sites of action of the neuropeptide Y/Y5 receptor system in the control of cortical/limbic function. The presence of Y5 immunoreactivity on cell bodies and proximal dendritic processes in specific regions of the hippocampus suggests that this receptor functions to modulate postsynaptic activity. These data also suggest that the neuropeptide Y/Y5 system may play a role in the modulation of a specific population of GABAergic neurons in the cortex, namely those that contain corticotropin-releasing hormone. The location of the Y5 receptor immunoreactivity fits with the known physiological actions of neuropeptide Y and this receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036207     DOI: 10.1016/s0306-4522(00)00308-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet.

Authors:  B E Grayson; P R Levasseur; S M Williams; M S Smith; D L Marks; K L Grove
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

2.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Maternal and postnatal high-fat diet consumption programs energy balance and hypothalamic melanocortin signaling in nonhuman primate offspring.

Authors:  Elinor L Sullivan; Heidi M Rivera; Cadence A True; Juliana G Franco; Karalee Baquero; Tyler A Dean; Jeanette C Valleau; Diana L Takahashi; Tim Frazee; Genevieve Hanna; Melissa A Kirigiti; Leigh A Bauman; Kevin L Grove; Paul Kievit
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-12       Impact factor: 3.619

4.  Activation of NPY type 5 receptors induces a long-lasting increase in spontaneous GABA release from cerebellar inhibitory interneurons.

Authors:  C J Dubois; P Ramamoorthy; M D Whim; S J Liu
Journal:  J Neurophysiol       Date:  2011-12-21       Impact factor: 2.714

5.  Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring.

Authors:  Elinor L Sullivan; Bernadette Grayson; Diana Takahashi; Nicola Robertson; Adriane Maier; Cynthia L Bethea; M Susan Smith; Kristine Coleman; Kevin L Grove
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

6.  Distribution of NPY Y5-like immunoreactivity in the rat brain.

Authors:  S Michelle Morin; Donald R Gehlert
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

7.  The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Authors:  Suzanne R Burstein; Tanya J Williams; Diane A Lane; Margarete G Knudsen; Virginia M Pickel; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

8.  Suppression of basal spontaneous gonadotropin-releasing hormone neuronal activity during lactation: role of inhibitory effects of neuropeptide Y.

Authors:  Jing Xu; Melissa A Kirigiti; Michael A Cowley; Kevin L Grove; M Susan Smith
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

9.  Candidate genes in ocular dominance plasticity.

Authors:  M Liset Rietman; J-P Sommeijer; Christiaan N Levelt; J Alexander Heimel
Journal:  Front Neurosci       Date:  2012-02-01       Impact factor: 4.677

10.  Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats.

Authors:  A Bari; A Dec; A W Lee; J Lee; D Song; E Dale; J Peterson; S Zorn; X Huang; B Campbell; T W Robbins; A R West
Journal:  Psychopharmacology (Berl)       Date:  2014-09-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.